The two companies will co-develop an oral JAK1/JAK2 inhibitor in myelofibrosis and likely other indications as well. read more
Labeling for additional indication for newly diagnosed patients cautions about higher virologic failure in treatment-nave patients receiving maraviroc during the clinical trial. read more
During a Nov. 25 briefing, White House officials reinforced the administration's support for an advisory panel focused on reining in Medicare costs on an ongoing basis and in a way that minimizes the political fallout from those cuts. read more
Loucks, one of the most prominent prosecutors of health care fraud, spent his last day at the Department of Justice on Nov. 25, but may remain in the health care field. read more
If approved, the interferon could offer a dosing advantage over pegylated interferons, although safety data could mean a bumpy regulatory road ahead. read more
Agency accepts industry comments on testing issue, but document may still contain hurdles for approval of some generic drugs. read more
The sponsored Google search result for Yaz gives no indication and links user to "full safety and prescribing information, including a boxed warning." read more
Food safety reform bill does not similarly exclude ingredient suppliers, who would presumably be subject to hazard analysis and critical control point-like rules. read more
"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here
